U.S. drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to development of their COVID-19 vaccine had been "unlawfully accessed" in a cyberattack on Europe's medicines regulator.
Emer McCarthy reports.
AstraZeneca-Oxford COVID vaccine approved for use in UK
Al Jazeera STUDIO
The UK authorises use of a second COVID-19 vaccine weeks after it approved Pfizer-BioNTech vaccine against the virus.
